Sixth nerve palsy following botulinum toxin injection for facial rejuvenation
| Autor: | Fariz Sadigov, Senem Salar-Gomceli, Ayse Dolar Bilge |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
Weakness
medicine.medical_specialty Facial rejuvenation Injections Subcutaneous Cosmetic Techniques Toxicology complex mixtures Injections Intramuscular Sixth nerve palsy 030207 dermatology & venereal diseases 03 medical and health sciences 0302 clinical medicine medicine Humans Medication Errors Rejuvenation 030212 general & internal medicine Prospective Studies Botulinum Toxins Type A Adverse effect Randomized Controlled Trials as Topic Diplopia business.industry General Medicine Middle Aged medicine.disease Glabella Botulinum toxin Surgery Skin Aging medicine.anatomical_structure Neuromuscular Agents Anesthesia Face Forehead Female medicine.symptom business medicine.drug Abducens Nerve Diseases |
| Zdroj: | Cutaneous and ocular toxicology. 36(2) |
| ISSN: | 1556-9535 |
| Popis: | Background: Botulinum toxin A (BTX) has been widely used for a variety of facial esthetic procedures within the last couple of decades. Efficacy and safety of BTX for facial rejuvenation has been extensively studied in multiple randomized prospective controlled trials. Focal weakness is among the most commonly reported adverse effects. Adverse reactions tend to occur most commonly due to errors in dosing formulation and errors with the techniques of the application. No serious long-term complications have been reported.Main observation: We present the case of a 52-year-old female presenting with diplopia one week following the injection of BTX for facial rejuvenation at glabella, forehead and crow’s feet areas.Conclusions: Injection of BTX adjacent to periorbital area may be associated with extra-ocular muscle paralysis. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|